作者: Robert Strunk , Michael R. DeBaun , Jeffrey A. Glassberg
DOI:
关键词:
摘要: Summary Wheezing in SCD should be treated aggressively both the acute setting and with controller medications. Prospective SCD-specific clinical trials will necessary to address whether anti-inflammatory asthma therapies (leukotriene antagonists, inhaled corticosteroids) can safely mitigate sequelae of wheezing SCD.